Neighborhood socioeconomic status (nSES) is associated with cardiovascular morbidity and mortality in the general population; however, its effect on high-risk patients with prevalent coronary artery disease (CAD) is unclear. We hypothesized "double jeopardy," whereby the association between nSES and adverse outcomes would be greater in high-risk patients with heart failure (HF) and/or prior myocardial infarction (MI) compared to those without. We followed 3,635 individuals (mean age 63.2 years, 42% with HF, 25% with prior MI) with known or suspected CAD over a median of 3.3 years for all-cause death and cardiovascular death or nonfatal MI. Individuals were categorized by a composite nSES score, and proportional hazards models were used to determine the association between nSES and outcomes. Cross-product interaction terms for prior MI x nSES and HF x nSES were analyzed. Compared to high nSES individuals, low nSES individuals had increased risk of all-cause death (hazard ratio [HR] = 1.61; 95% CI = 1.20, 2.15) and cardiovascular death or MI (subdistrubution hazard ratio [sHR] = 1.82; 95% CI = 1.30, 2.54). Associations were more pronounced among patients without HF or prior MI. Low nSES individuals without HF had a higher risk of all-cause death (HR = 2.27; 95% CI = 1.41, 3.65) compared to those with HF (HR = 1.21; 95% CI = 0.82, 1.77, P-interaction = 0.04). Similarly, low nSES individuals without prior MI had a higher risk of cardiovascular death or MI (sHR = 2.72; 95% CI = 1.73, 4.28) compared to those with prior MI (sHR = 1.02; 95% CI = 0.58, Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Introduction
Neighborhood socioeconomic status (nSES) is a key social determinant of health, 1 and its association with cardiovascular health in the general population is well-established. [2] [3] [4] [5] [6] [7] [8] [9] Neighborhood deprivation and low nSES are additionally associated with adverse outcomes in patients with heart failure, 10 stroke, 11 and those hospitalized for acute myocardial infarction (MI); 12 however, findings are inconsistent across disease type and outcome of interest. 13, 14 Most studies suggest a "double jeopardy" hypothesis, whereby risk of adverse events is compounded by the simultaneous presence of low nSES and high-risk clinical cardiovascular disease (CVD), but explicit investigations of the interaction between nSES, CVD and adverse outcomes are lacking. We sought to investigate the associations between nSES and adverse outcomes in a cohort of patients with prevalent coronary artery disease (CAD), specifically exploring whether the association between nSES and adverse outcomes is modified by high-risk prevalent CVD. We hypothesized that individuals living in low nSES areas would have worse outcomes, and that the association of low nSES would be greater among individuals with heart failure or prior MI.
Methods
We studied 3,635 adults, aged 21 years and older enrolled in the Emory Cardiovascular Biobank, a prospective cohort of patients undergoing left heart catheterization for suspected or confirmed CAD in Atlanta, GA, between 2004 and 2014. Participants were interviewed to collect demographic characteristics, medical history, medication use, and behavioral habits. Individuals with previous cardiac transplantation or under consideration for transplant were excluded. All participants provided written informed consent at the time of enrollment, and the study was approved by the institutional review board at Emory University (Atlanta, GA).
Participants' residential addresses were geocoded using latitude and longitude coordinates with ArcMap 10.2 (Environmental Systems Research Institute (ESRI), Inc., Redlands, California) and 2010 US Census TIGER/Line Shapefiles based on the North American Industry Classification. Nine percent of individuals were not located in the state of Georgia (n=463) and were excluded due to incomplete follow-up. Additionally, 19% of individuals were unmatched due to missing addresses, use of P.O. boxes, or were not located by the GIS-software (n=967). Compared to individuals outside of Georgia or those who were not geocoded, geocoded individuals were younger, more likely to be black, more likely to have a history of smoking and hypertension, and less likely to use antihypertensive medications or have a history of revascularization.
Using the geocoded coordinates, data from the 2006-2010 United States Census Bureau's American Community Survey (ACS) 5-year estimates were merged with clinical data at the census-tract level for residents living in Georgia, resulting in 3,635 participants who represented 1,114 census tracts across Georgia. The median number of individuals per census tract was 2 [IQR [1] [2] [3] [4] , and the maximum number of individuals from any census tract was 22.
As previously described, 6 , 15 a composite neighborhood socioeconomic score (nSES) was determined from six census variables: 1) median household income; 2) median value of owner-occupied housing units; 3) percentage of adults ≥ 25 years of age who have graduated high school; 4) percentage of adults ≥ 25 years of age who have graduated college; 5) percentage of persons in management, business, science and arts occupations; and 6) percentage of households with interest, dividend or rental income. Median household income and median value of housing units were log-transformed due to their skewed distributions, and each variable was standardized and summed together to create an overall Z score, which ranged from −12.62 (lowest) to 16.67 (highest). Summary scores were separated by quartiles and categorized into three groups: Low nSES (quartile 1, nSES score −12.62 to −3.96), Middle nSES (quartiles 2 and 3, nSES score −3.96 to 3.34) and High nSES (quartile 4, nSES score 3.34 to 16.67). High nSES served as the referent group and represented individuals from neighborhoods with greatest socioeconomic advantage.
Individuals enrolled in the Emory Cardiovascular Biobank underwent a detailed baseline evaluation using standardized self-report questionnaires and medical records review. Age (years), sex (male vs. female), race (white vs. black), and smoking (current or former vs. never) were obtained by self-report. Additionally, medical history was obtained by selfreport and confirmed by medical records evaluation and/or medication use for the following conditions: hypertension, diabetes, hyperlipidemia, heart failure, prior MI, and prior revascularization (either percutaneous coronary intervention or coronary artery bypass grafting). Individuals were additionally categorized by the presence or absence of an acute coronary syndrome on presentation for cardiac catheterization. Body mass index (in kg/m 2 ) and systolic blood pressure (SBP, in mm Hg) were measured by trained staff. Routine laboratory data included fasting values of low-density lipoprotein cholesterol (LDL-C) and serum creatinine (mg/dL), which was used to calculate the estimated glomerular filtration rate (eGFR, in ml/min/1.73 m 2 ). All participants underwent a detailed medication questionnaire to document use of the following: anti-hypertensives (angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, beta blockers), aspirin, clopidogrel and statins. Obstructive CAD was defined as the presence of ≥ 50% stenosis at least 1 major epicardial vessel.
Follow-up was conducted by phone, electronic medical record review, social security death index and state records to identify cardiovascular death or non-fatal MI. Cardiovascular death was defined as death from MI, heart failure, sudden death, stroke, pulmonary embolization or as a complication during any cardiovascular-related procedure. MI was defined according to relevant medical history, diagnostic cardiac enzymes, and/or electrocardiogram tracing consistent with myocardial injury. Event adjudication was conducted by two independent, board-certified cardiologists blinded to baseline characteristics.
Demographic factors, education, marital status, nSES, clinical risk factors, biomarkers and outcomes were reported, by nSES group, as n (%) or mean ± SD. Analysis of variance (continuous, normally-distributed variables) and the chi-square test (categorical variables) were used to compare baseline clinical characteristics between groups of nSES.
The cumulative incidences of all-cause death and cardiovascular death or MI were plotted as (1-survival) for each nSES groups. Follow-up time was defined as the time from enrollment until one of the following: death, cardiovascular death, MI, loss to follow-up, or end of follow-up. Cox proportional hazard models were used to determine the association between nSES and all-cause death. We performed competing risk analyses for cardiovascular death or MI using Fine and Gray's method, treating non-cardiovascular death as a competing risk, and stepwise proportional hazards models were used to determine the association between nSES category and outcomes. As previously described, high nSES was used as the reference. There were no violations of the proportional hazards assumption. A robust sandwich estimator was used to account for residual correlation among individuals living in the same census tract. 16 Modeling steps were performed to determine the effect of additional adjustment for levels of risk factors. Sensitivity analysis was performed in a subset of patients with stable CAD and excluded patients with normal coronary arteries (n=370) and those presenting with ACS (n=351). Cross product interaction terms for nSES x prior MI and nSES x heart failure were specifically tested to determine if the association between low nSES and outcomes differed by severity of prevalent CVD, as these conditions are associated with particularly high rates of adverse outcomes. Further stratified analyses were performed for prior revascularization, ACS on admission, age (<60 years vs. ≥60 years), race, sex, aspirin use and statin use. Statistical significance was defined as p <0.05 (2-sided) for all main effects and interaction terms. SAS Version 9.4 (Cary, NC) was used for all analyses.
Results
Overall, the study cohort consisted of 3,635 individuals. Low nSES individuals were younger, more likely to be female and black, and were less likely to be married or college graduates (Table 1) . Additionally, the prevalence of traditional cardiovascular risk factors and heart failure was higher, while the use of statins and aspirin was lower, among lower nSES individuals (Table 1) .
Over a median follow-up period of 3.3 years (interquartile range, 1.6-6.4 years), a total of 610 (17%) all-cause deaths, 369 (10%) cardiovascular deaths, and 188 (5%) MIs occurred. The cumulative incidence for all-cause death and cardiovascular death or MI with respect to nSES are shown in Figure 1 . There was a stepwise increase in the risk of adverse outcomes with decreasing nSES. Compared to high nSES individuals, those in the middle and low nSES groups had increased risk of all-cause death and cardiovascular death or MI (Table 2) . After adjustment for demographics, education, marital status and clinical risk factors, the association between nSES and adverse outcomes was attenuated for middle nSES individuals but remained statistically significant for low nSES individuals (Table 2) . Similar findings were found in a subset of individuals with stable CAD (Table 3) .
The absolute incidence rates of all-cause death and cardiovascular death or MI were greater in patients with a history of heart failure or prior MI at all levels of nSES (Table 4) . There was a significant interaction between low nSES and heart failure for the outcome of allcause death; those without heart failure had a higher risk for death than those with heart failure ( Figure 2) . Similarly, there was a significant interaction between low nSES and prior MI for the outcome of cardiovascular death or MI; those without prior MI had a higher risk for cardiovascular death or MI than those without prior MI (Figure 2 ).
Sensitivity analyses revealed no significant interactions between low nSES and age (<60 years vs. ≥60 years), race (white vs. black), sex (male vs. female) prior revascularization, ACS on admission, aspirin use or statin use (all P-interaction > 0.10).
Discussion
In this study, we demonstrate that among high-risk individuals with CAD, living in census tracts with low compared to high nSES is independently associated with an increased risk of all-cause death and cardiovascular death or MI, irrespective of demographic, clinical or individual-level SES characteristics. Furthermore, despite a higher absolute adverse event rate in patients with heart failure or prior MI, the relative association between low nSES and adverse outcomes was greater in those without heart failure or prior MI. This is in contrast to our expected hypothesis that the combination of low nSES and cardiovascular disease would be associated with worse outcomes and prompts inquiry into the cause of this seeming paradox.
While population studies have shown a consistent association between lower nSES and worse CVD outcomes; 3-9 data from high-risk CV cohorts are varied. In patients with acute events, such as MI or stroke, disparities in outcomes between low and high nSES individuals are typically attributed to differences in processes of care. 13, 14 Furthermore, these associations between nSES and outcomes are largely attenuated after accounting for individual-level SES and other high-risk clinical morbidities. 5 And although most studies suggest that the combination of low nSES and prevalent CVD result in worse outcomes, few have explicitly sought to answer this question. Surprisingly, in those that have, the associations between low nSES and adverse outcomes were either equivalent to 17 or more pronounced 18 in patients without CVD than in those with CVD. Because our study had similarly unexpected findings, further exploration is warranted.
At the individual level, perhaps a history of heart failure or MI is "protective" in low nSES patients. Previous studies have shown that low nSES individuals generally receive secondary preventive medications and/or procedural intervention less than high nSES individuals; 19 however, individuals with high-risk cardiovascular histories are more likely to follow-up with providers 20 and be prescribed secondary preventive medication. 21 It is possible that higher healthcare surveillance or treatment in patients with heart failure or prior MI offsets the lower rates of evidence-based care that low nSES patients typically receive. At the neighborhood level, several hypotheses are possible, and it is still unclear what nSES is a proxy for in ascribing overall cardiovascular risk. The nSES variable is comprised of only six variables, primarily relating to the income, wealth, occupation and education of the census tract at large; however, several other exposures with biomechanistic ties to heart failure and prior MI follow along nSES gradients and may help explain the excess burden of disease in low nSES individuals. Adverse neighborhood and built environment characteristics such as social isolation, 22 violent crime, 23 pollution 24 and proximity to roadways 25 have all been associated with CVD and cluster in lower nSES areas. Additionally, food access and diet quality are tightly aligned with nSES and cardiovascular health and may be important in determining how nSES adds to the individual risk profile. 26 That these factors would more adversely affect individuals without heart failure or prior MI is unexpected and cannot be readily explained by our data; however, the impact of social support on improved outcomes in high-risk patients with CVD may be especially important. 27 Although social support is associated with improved self-care behaviors in patients with prevalent CVD, 28 neighborhood poverty is associated with lower overall social integration. 29 Overall, low nSES individuals without high-risk CVD, such as heart failure or prior MI, may have less exposure to healthcare and less robust social support -these factors would result in a unique vulnerability to adverse outcomes.
This study has several limitations that merit discussion for appropriate context. Assessment of exposures occurred at a single time point and therefore precludes any inference of causality between nSES and outcomes. Furthermore, we do not have residential mobility information on our cohort; however, previous studies have shown that even when individuals move, they generally move laterally within nSES strata. 30 All participants were limited to the state of Georgia, which affects the generalizability of our findings and may mask regional influences specific to the Southeast United States regarding the associations between nSES and adverse cardiovascular outcomes. Furthermore, because not all subjects enrolled in the Emory Cardiovascular Biobank were able to be geocoded, there is potential selection bias. Individuals who have survived an initial MI or diagnosis of heart failure are more likely to survive in the long-term, and survival bias cannot be excluded, however, it is less likely given that those with high-risk CVD experienced higher crude rates of adverse events. Lastly, given the observational nature of this analysis, residual confounding at both the neighborhood and individual level are possible contributors to bias in our study.
In conclusion, our study showed that neighborhood SES was independently associated with adverse outcomes in a high-risk cohort of patients with CAD after adjustment for individuallevel traditional risk factors. Furthermore, the association between low nSES on incident allcause death and cardiovascular death or MI was greater in individuals without a history of heart failure or MI. Identifying mechanisms to improve care delivery to high-risk, low nSES individuals without prevalent CVD may help close nSES-related disparities in cardiovascular disease outcomes. 
